185 filings
Page 7 of 10
8-K
9ywqb 71usrzwuqet3i
10 Jun 22
Submission of Matters to a Vote of Security Holders
8:30am
EFFECT
img4pv gkh
9 Jun 22
Notice of effectiveness
12:15am
424B3
h4ury5mg
8 Jun 22
Prospectus supplement
4:43pm
CORRESP
hk9abb13zn5ps
6 Jun 22
Correspondence with SEC
12:00am
UPLOAD
079ow5qim
3 Jun 22
Letter from SEC
12:00am
PRE 14A
y3jukghvk0p 0j7l
25 May 22
Preliminary proxy
11:58am
8-K
ec6kvsldqj
18 May 22
Unregistered Sales of Equity Securities
5:07pm
8-K
70dgpbt
13 May 22
Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering
5:12pm
424B5
ku5f1x6sl g685scmfya
13 May 22
Prospectus supplement for primary offering
5:08pm
8-K
8zohrbs 71a8svt8vem
12 May 22
Vallon Pharmaceuticals Reports Additional Pharmacokinetic and Pharmacodynamic Data from SEAL Study of ADAIR
8:37am
8-K
u8vt8da wu6y
9 May 22
Vallon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:08pm
EFFECT
ax413i
3 May 22
Notice of effectiveness
12:15am
424B3
dwvt7z2i
2 May 22
Prospectus supplement
4:41pm
UPLOAD
a95qg40zu736v7
28 Apr 22
Letter from SEC
12:00am
CORRESP
lcmslcaapm3o
28 Apr 22
Correspondence with SEC
12:00am
DEFA14A
7zu18qv74p8u7x
27 Apr 22
Additional proxy soliciting materials
4:06pm
DEF 14A
bylgd9ca
27 Apr 22
Definitive proxy
4:05pm